New share for trading, Unibap AB (68/17) At the request

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GQG Partners Introduces First Active ETF GQG Partners, an emerging player in the financial services sector, is excited to announce its plans to launch the GQG US Equity ETF, marking its entry into the active ETF market. This innovative exchange-traded fund (ETF) will be available to U.S. investors in the upcoming summer season and is set to be listed under the ticker...

Whimsocal Studios Launches as a New House of Happy Brands Whimsocal Studios has emerged as an exciting new parent company dedicated to creating joyful and functional brands that resonate with modern consumers. This innovative organization aims to enhance everyday life through thoughtful design and high-quality products. A Fusion of Celebratory Brands Whimsocal Studios...

Bully Max Shines at the Prestigious Advertising Awards Bully Max, renowned for its premium performance dog food, has made headlines by securing significant wins at the American Advertising Awards. The event took place at the enchanting Phipps Conservatory, where creativity and excellence were on full display. Crowning Achievement: Gold ADDY Award for Excellence The...

Changing Times for Gen Z Entrepreneurs Climbing the corporate ladder can feel like a long journey, but think about this: what if the next person giving orders is a Gen Z dropout? With the rising cost of living and the diminishing appeal of traditional college education, many young individuals from this generation are increasingly turning to start their own ventures. The...

Record Performance from Diversified Royalty Corp. Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) has announced impressive financial results for the three months ended June 30, 2025, marking their strongest adjusted revenue quarter in company history. As a multi-royalty corporation, DIV is dedicated to acquiring top-line royalties from well-managed businesses and...